Thursday - April 25, 2024

Category Archives: Finance

Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Sandoz, Opthea, Alkahest, PanOptica, AsclepiX

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 75+ key pharma and biotech companies are working on 80+ pipeline drugs in the Wet Age-Related Macular Degeneration (Wet AMD) therapeutics landscape based on different Routes of Administration (ROA), Mechanism … Continue reading →

Peripheral Arterial Disease (PAD) Market: Latest Study by DelveInsight Reveals a Lucrative Investment Opportunity and Growth Prospect | Novo Nordisk, Takeda, Ixaka, Athersys, ARCA biopharma, Ambulero

Delveinsight Business Research LLP The Peripheral Arterial Disease Market size was found to be USD 3,930 million in 2022, and it is expected to increase by 2032. As per DelveInsight, the Peripheral Arterial Disease Market is anticipated to evolve immensely … Continue reading →

Peritoneal Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Seagen, Mersana, ImmunoGen, Elucida, Rhizen, Green3Bio, Oncoinvent, OncoMed

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Peritoneal Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

AL Amyloidosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Caelum, Nexcella, HaemaLogiX, Prothena, ZENTALIS, Sorrento Therapeutics

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the AL Amyloidosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Glioblastoma Multiforme (GBM) Market to Grow at a Substantial Growth Rate During the Forecast Period (2023-2032) – DelveInsight | Bayer, MedImmune, DNAtrix, Chimerix, Medicenna, Genentech, Merck

Delveinsight Business Research LLP The Glioblastoma Multiforme Market size in the seven major markets was estimated to be USD 1,022.1 Million in 2020, which is expected to grow by 2032. As per DelveInsight, the Glioblastoma Multiforme Market is anticipated to … Continue reading →